Addus HomeCare Corporation $ADUS Shares Bought by Inspire Investing LLC

Inspire Investing LLC raised its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 9.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,470 shares of the company’s stock after purchasing an additional 294 shares during the quarter. Inspire Investing LLC’s holdings in Addus HomeCare were worth $343,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ADUS. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Addus HomeCare during the 1st quarter valued at about $41,000. Caitong International Asset Management Co. Ltd grew its stake in Addus HomeCare by 368.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company’s stock valued at $124,000 after purchasing an additional 987 shares during the last quarter. Bailard Inc. purchased a new stake in Addus HomeCare during the 1st quarter valued at about $208,000. Heritage Family Offices LLP grew its stake in Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company’s stock valued at $239,000 after purchasing an additional 143 shares during the last quarter. Finally, Private Advisor Group LLC grew its stake in Addus HomeCare by 52.4% during the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company’s stock valued at $252,000 after purchasing an additional 875 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the sale, the chief executive officer owned 166,461 shares of the company’s stock, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the sale, the director directly owned 5,067 shares of the company’s stock, valued at approximately $582,350.31. This represents a 23.67% decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock valued at $3,958,375 over the last quarter. 4.50% of the stock is currently owned by insiders.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $108.35 on Wednesday. The company has a market capitalization of $2.00 billion, a P/E ratio of 23.92, a P/E/G ratio of 1.66 and a beta of 0.85. The business’s 50 day moving average is $111.87 and its two-hundred day moving average is $107.39. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. During the same quarter in the prior year, the business posted $1.35 earnings per share. Addus HomeCare’s revenue for the quarter was up 21.8% on a year-over-year basis. Analysts expect that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ADUS. TD Cowen boosted their price target on Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Barclays upped their target price on Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 19th. JMP Securities restated a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Macquarie restated an “outperform” rating and issued a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, UBS Group initiated coverage on Addus HomeCare in a research note on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $138.89.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.